| Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung Cancer H Kitai, H Ebi, S Tomida, KV Floros, H Kotani, Y Adachi, S Oizumi, ... Cancer discovery 6 (7), 754-769, 2016 | 168 | 2016 |
| Epithelial-to-mesenchymal transition antagonizes response to targeted therapies in lung cancer by suppressing BIM KA Song, MJ Niederst, TL Lochmann, AN Hata, H Kitai, J Ham, KV Floros, ... Clinical Cancer Research 24 (1), 197-208, 2018 | 88 | 2018 |
| Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression H Kotani, H Ebi, H Kitai, S Nanjo, K Kita, TG Huynh, A Ooi, AC Faber, ... Oncogene 35 (27), 3587-3597, 2016 | 39 | 2016 |
| Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer H Kitai, H Ebi Small GTPases 8 (3), 172-176, 2017 | 33 | 2017 |
| Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers H Kotani, Y Adachi, H Kitai, S Tomida, H Bando, AC Faber, T Yoshino, ... Oncogene 37 (13), 1775-1787, 2018 | 31 | 2018 |
| Spontaneous regression of small cell lung cancer combined with cancer associated retinopathy H Kitai, J Sakakibara-Konishi, S Oizumi, Y Hirohashi, W Saito, A Kanda, ... Lung Cancer 87 (1), 73-76, 2015 | 24 | 2015 |
| Response to crizotinib re-administration after progression on lorlatinib in a patient with ALK-rearranged non–small-cell lung cancer J Sakakibara-Konishi, H Kitai, Y Ikezawa, Y Hatanaka, T Sasaki, ... Clinical lung cancer 20 (5), e555-e559, 2019 | 23 | 2019 |
| Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer Y Adachi, K Watanabe, K Kita, H Kitai, H Kotani, Y Sato, N Inase, S Yano, ... Carcinogenesis 38 (11), 1063-1072, 2017 | 23 | 2017 |
| Response of BRAFV600E-mutant lung adenocarcinoma with brain metastasis and leptomeningeal dissemination to dabrafenib plus trametinib treatment G Yamamoto, J Sakakibara-Konishi, T Ikari, H Kitai, H Mizugaki, ... Journal of Thoracic Oncology 14 (5), e97-e99, 2019 | 11 | 2019 |
| Improvements of visual function and outer retinal morphology following spontaneous regression of cancer in anti-recoverin cancer-associated retinopathy Y Suimon, W Saito, K Hirooka, A Kanda, H Kitai, J Sakakibara-Konishi, ... American Journal of Ophthalmology Case Reports 5, 137-140, 2017 | 10 | 2017 |
| The bi-steric mTORC1-selective inhibitor RMC-5552 in tumors with activation of mTOR signaling: Preclinical activity in combination with RAS (ON) inhibitors in RAS-addicted … HA Burris III, SV Ulahannan, EB Haura, SHI Ou, A Capasso, PN Munster, ... Journal of Clinical Oncology 40 (16_suppl), 3098-3098, 2022 | 6 | 2022 |
| Recurrence of renal cell carcinoma diagnosed using contralateral adrenal biopsy with endoscopic ultrasound-guided fine-needle aspiration A Tanimoto, S Takeuchi, H Yaegashi, H Kotani, H Kitai, S Nanjo, H Ebi, ... Molecular and Clinical Oncology 4 (4), 537-540, 2016 | 5 | 2016 |
| Response to First-Line Osimertinib Treatment in Non–Small-Cell Lung Cancer With Coexisting G719A and Primary T790M Epidermal Growth Factor Receptor Mutations T Ikari, J Sakakibara-Konishi, G Yamamoto, H Kitai, H Mizugaki, ... Clinical Lung Cancer 20 (4), e531-e533, 2019 | 3 | 2019 |
| Efficacy of pemetrexed in advanced non-small cell lung cancer with asymptomatic brain metastases H Kitai, H Asahina, T Takashina, Y Ikezawa, J Sakakibara-Konishi, ... JOURNAL OF THORACIC ONCOLOGY 8, S867-S867, 2013 | 1 | 2013 |
| Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer H Kitai, PH Choi, YC Yang, JA Boyer, A Whaley, P Pancholi, C Thant, ... Nature Communications 15 (1), 6076, 2024 | | 2024 |
| Oncogene alterations in non-small cell lung cancer with FGFR1 amplification—novel approach to stratify patients who benefit from FGFR inhibitors H Kitai, H Ebi Translational Lung Cancer Research 13 (3), 684, 2024 | | 2024 |
| Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer K Tsuji, E Kikuchi, Y Takashima, T Shoji, H Takahashi, S Ito, D Morinaga, ... Cell Cycle 22 (17), 1854-1864, 2023 | | 2023 |
| Performance of ROS1 fusion gene test using FFPE tissue and bronchoscopic cytologic specimen K Tsuji, N Shinagawa, H Kitai, T Ikari, M Sato, H Takahashi, M Kunisaki, ... European Respiratory Journal 54 (suppl 63), 2019 | | 2019 |
| Retrospective analysis of tumor programmed death-ligand 1 expression in transbronchial biopsy samples H Takahashi, N Shinagawa, Y Hatanaka, M Kunisaki, M Furuta, ... European Respiratory Journal 52 (suppl 62), 2018 | | 2018 |
| Usefulness of automatic pulmonary artery extraction in bronchoscopic navigation system M Kunisaki, N Shinagawa, H Takahashi, Y Takashima, M Furuta, T Shoji, ... European Respiratory Journal 52 (suppl 62), 2018 | | 2018 |
